Advertisement
<< Back To Article
Trump’s Assumed FDA Pick Has a Controversial View on Drug Approvals

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

5 Comments

b.t.,RN

If the free market brought drug prices down, the U.S. would not have the highest drug prices in the world. This repeatedly disproven canard belongs on the shelf next to trickle-down economics. The safety of any individual drug is never "proven;" some harms become evident only after years, or in certain groups of people. Current drug approvals give industry too much "benefit of the doubt" re: harm, but at least there is some weighting of benefit:risk.

December 14, 2016 NY metro area

Thomas

Here here! I much prefer the current process, that sees proven therapies rot on the vine for lack of urgency and promising treatment horizons extinguished. Much better that we should continue at the snail's pace of current research-even if we die for that stagnation-than even once utter the words "free market" when talking about drugs which already cost more than a house. Thank heavens we have the sage wisdom of protectionist Poz to guide us!

December 14, 2016 Minneapolis, MN

Bayhuntr

"In a 2014 speech, he supported reforming the way the FDA approves drugs for consumers. Basically, drugs should be sold once they are proven to be safe—regardless of whether they actually work" This man doesn't understand the free market or healthcare. I'm guessing he got rich because he's good at rubbing elbows in playing golf.

December 13, 2016

Greg H.

A free market won't fix anything. The problem in this country is capitalistic medicine. We rank 37th in the world. We spend more per capita than any other country on the planet and get less for it. Our current system makes it profitable to keep people sick. We have a disease management system rather than a healthcare system. Insurance companies need to go away, and it should be "Medicare for all."

December 13, 2016 Davenport, FL

ehart

yet another effing idiot appointed by tRump.

December 13, 2016

Advertisement

Hot topics